Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Allegro

This page shows the latest Allegro news and features for those working in and with pharma, biotech and healthcare.

Not your average training programme: why does allegro work so well?

Not your average training programme: why does allegro work so well?

The allegro programme, established at Ashfield Healthcare Communications in 2018, is designed to train and develop competent, motivated, well-networked medical writers. ... This year allegro celebrated the graduation of its 100. th. medical writer, a

Latest news

  • Ashfield wins gold at the UK Employee Experience Awards Ashfield wins gold at the UK Employee Experience Awards

    Fast-track for medical writers impresses judges. Ashfield Healthcare Communications has won gold for its medical writing training programme allegro at the UK Employee Experience Awards 2019. ... The allegro team attended the awards last week and took

  • GCI Health expands into Asia, Lucid adds to Futures Academy and more GCI Health expands into Asia, Lucid adds to Futures Academy and more

    Ashfield’s medical writers graduate. Ashfield Healthcare Communications has seen its first cohort of medical writers graduate from training programme Allegro. ... The company plans to increase recruitment to Allegro this year, expanding the geographic

  • ROAD wins new account, Ark rebrands and Ashfield sees third intake of writers ROAD wins new account, Ark rebrands and Ashfield sees third intake of writers

    Ashfield’s Allegro welcomes third intake of medical writers. Following on the from the success of the first two intakes, 15 more employees joined the business as associate medical writers, and ... The Allegro programme has been designed to ensure

  • Ashfield welcomes second intake of medical writers Ashfield welcomes second intake of medical writers

    Neil Marmont, Allegro’s programme director, said: “The 15 associate medical writers who joined Allegro in January have all successful completed the eight-week training curriculum and are now delivering work ... Ashfield aims to train up to 80 writers

  • Multiplying options for MS

    Gilenya. In December 2010, top-line results from the pivotal phase III ALLEGRO trial were announced, indicating that the drug met its primary endpoint of reducing annualised relapse rates in patients ... Completion of this trial is expected later in 2011.

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Founded in 201, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...

Quick links